SLU-PP-332 Reference

Plain English

What it is

SLU-PP-332 is a lab-made research chemical, not an approved medicine and not actually a peptide. It is a small molecule that switches on a group of cell proteins called estrogen-related receptors (ERRs), which is why scientists call it an 'exercise mimetic,' meaning something that tries to copy the effects of exercise.

What people use it for

People in the 'exercise mimetic' crowd talk about it for losing fat and improving endurance. Every one of those claims is borrowed from animal studies, not from research in people.

What the science shows

In mice, it raised how much energy and fat the body burned, lowered fat mass, and improved exercise capacity. All of the published research is in rodents, and there is no published human trial.

The catch

This is an unapproved research chemical with no FDA label and no human safety or effectiveness data at all. Strong results in mice do not mean it works or is safe in people, so the fat-loss and endurance claims remain unproven in humans.

Reference summary

Published work is preclinical, focused on mechanism-of-action in ERR signaling and rodent phenotypes (improved endurance and reduced fat mass in diet-induced obesity). There is no published human clinical program.

Regulatory and posture

Categories

Metabolic, Fat Loss

Aliases

ERR pan-agonist, Exercise-mimetic small molecule, Non-peptide small molecule

Evidence posture

preclinical - Rodent exercise-mimetic data only. No published human clinical program for SLU-PP-332. Community weight-loss / endurance framing extrapolates from mouse models.

Regulatory status

No FDA-approved SLU-PP-332 drug label. SLU-PP-332 is a non-peptide small-molecule pan-agonist of the estrogen-related receptor (ERR) family studied as an exercise-mimetic in rodent obesity and metabolic models.

Content review status

research reference